Clinical Trials
2 trialsNCT06634030 2026-03-23
Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction
Vanderbilt University Medical Center
Phase 2 Recruiting
NCT00518102 2016-07-19
The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin])
Ethicon, Inc.
Completed